Skip to main content

Perrigo Company(PRGO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

PERRIGO RELEASES STATEMENT ON RECENT MARKET TRADING ACTIVITY

PR Newswire - Wed Aug 17, 2022

DUBLIN, Aug. 17, 2022 /PRNewswire/ -- In response to speculative commentary regarding ranitidine (Zantac®) litigation from a news story that contained certain misleading and inaccurate information, Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today issued the following statement:

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.